What is Apollomics Inc - Ordinary Shares - Class A Annual Net Profit?

Apollomics Inc - Ordinary Shares - Class A Annual Net Profit rose 68.8% in the last year to $53.86 M. Its sector's average net profit growth for the last fiscal year was -32.31%.

What is Apollomics Inc - Ordinary Shares - Class A Stock Price?

Apollomics Inc - Ordinary Shares - Class A Stock Price fell 84.64% and underperformed its sector by 93.39% in the past year.

What is Apollomics Inc - Ordinary Shares - Class A Debt to Equity Ratio?

Apollomics Inc - Ordinary Shares - Class A Debt to Equity Ratio of 0.2 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Apollomics Inc - Ordinary Shares - Class A Return on Equity(ROE)?

Apollomics Inc - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -233.67%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Apollomics Inc - Ordinary Shares - Class A Mutual Fund Holding?

Apollomics Inc - Ordinary Shares - Class A Mutual Fund Holding decreased by 1.07% in the last quarter to 0.05.

What is Apollomics Inc - Ordinary Shares - Class A Interest Coverage Ratio?

Apollomics Inc - Ordinary Shares - Class A Interest Coverage Ratio is -298.44, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Apollomics Inc - Ordinary Shares - Class A Institutional Holding?

Apollomics Inc - Ordinary Shares - Class A Institutional Holding decreased by 1.14% in the last quarter to 0.02.

Apollomics Inc - Ordinary Shares - Class A XNAS: APLM

Apollomics Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Apollomics Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Apollomics Inc - Ordinary Shares - Class A
Rating: 0.88400
Author: Trendlyne DVM scores

about

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pat...

6.09 -0.13 (-2.09%)

85.68% Fall from 52W High

16,158 XNAS Volume

XNAS 05 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

10.0 / 100

Technically Bearish

25.4 / 100

No estimates available

Apollomics Inc - Ordinary ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Apollomics Inc - Ordinary Shares - Class A FAQ

How is Apollomics Inc - Ordinary Shares - Class A today?

Apollomics Inc - Ordinary Shares - Class A today is trading in the red, and is down by -2.09% at 6.09.

How has Apollomics Inc - Ordinary Shares - Class A performed historically?

Apollomics Inc - Ordinary Shares - Class A is currently trading down -2.09% on an intraday basis. In the past week the stock fell -7.16%. stock has been down -32.26% in the past quarter and fell -84.64% in the past year. You can view this in the overview section.